Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.
| Image |  |
|---|---|
| Description | scientific article published on 17 July 2017 |
| Author/s |
author: Anna K. Nowak Paul K Stockman Alessandra Bearz Luana Calabro' Martina Puglisi Dariusz M Kowalski |
| Publication date | July 17, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |